Gut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
39691780
PubMed Central
PMC11650326
DOI
10.1016/j.isci.2024.111442
PII: S2589-0042(24)02669-5
Knihovny.cz E-zdroje
- Klíčová slova
- Gastroenterology, Microbiome,
- Publikační typ
- časopisecké články MeSH
Developing microbiome-based markers for pediatric inflammatory bowel disease (PIBD) is challenging. Here, we evaluated the diagnostic and prognostic potential of the gut microbiome in PIBD through a case-control study and cross-cohort analyses. In a Korean PIBD cohort (24 patients with PIBD, 43 controls), we observed that microbial diversity and composition shifted in patients with active PIBD versus controls and recovered at remission. We employed a differential abundance meta-analysis approach to identify microbial markers consistently associated with active inflammation and remission across seven PIBD cohorts from six countries (n = 1,670) including our dataset. Finally, we trained and tested various machine learning models for their ability to predict a patient's future remission based on baseline bacterial composition. An ensemble model trained with the amplicon sequence variants effectively predicted future remission of PIBD. This research highlights the gut microbiome's potential to guide precision therapy for PIBD.
CJ Bioscience Seoul 04527 Republic of Korea
Department of Integrative Biology and Physiology UCLA Los Angeles CA 957246 USA
Zobrazit více v PubMed
Sýkora J., Pomahačová R., Kreslová M., Cvalínová D., Štych P., Schwarz J. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J. Gastroenterol. 2018;24:2741–2763. PubMed PMC
Choe Y.J., Han K., Shim J.O. Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study. Aliment. Pharmacol. Ther. 2022;56:980–988. PubMed
Shim J.O., Seo J.K. Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations. J. Hum. Genet. 2014;59:337–341. PubMed
Lloyd-Price J., Arze C., Ananthakrishnan A.N., Schirmer M., Avila-Pacheco J., Poon T.W., Andrews E., Ajami N.J., Bonham K.S., Brislawn C.J., et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569:655–662. PubMed PMC
Narula N., Wong E.C.L., Dehghan M., Mente A., Rangarajan S., Lanas F., Lopez-Jaramillo P., Rohatgi P., Lakshmi P.V.M., Varma R.P., et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374 PubMed PMC
Dutta A.K., Chacko A. Influence of environmental factors on the onset and course of inflammatory bowel disease. World J. Gastroenterol. 2016;22:1088–1100. PubMed PMC
Vatn S., Carstens A., Kristoffersen A.B., Bergemalm D., Casén C., Moen A.E.F., Tannaes T.M., Lindstrøm J., Detlie T.E., Olbjørn C., et al. Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character) Scand. J. Gastroenterol. 2020;55:1146–1156. PubMed
Pascal V., Pozuelo M., Borruel N., Casellas F., Campos D., Santiago A., Martinez X., Varela E., Sarrabayrouse G., Machiels K., et al. A microbial signature for Crohn’s disease. Gut. 2017;66:813–822. PubMed PMC
Manandhar I., Alimadadi A., Aryal S., Munroe P.B., Joe B., Cheng X. Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases. Am. J. Physiol. Gastrointest. Liver Physiol. 2021;320:G328–G337. PubMed PMC
Hyams J.S., Davis Thomas S., Gotman N., Haberman Y., Karns R., Schirmer M., Mo A., Mack D.R., Boyle B., Griffiths A.M., et al. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Lancet. 2019;393:1708–1720. PubMed PMC
Höyhtyä M., Korpela K., Saqib S., Junkkari S., Nissilä E., Nikkonen A., Dikareva E., Salonen A., de Vos W.M., Kolho K.-L. Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2023;29:116–124. PubMed PMC
Hart L., Farbod Y., Szamosi J.C., Yamamoto M., Britz-McKibbin P., Halgren C., Zachos M., Pai N. Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease. Nutrients. 2020;12 PubMed PMC
Ananthakrishnan A.N., Luo C., Yajnik V., Khalili H., Garber J.J., Stevens B.W., Cleland T., Xavier R.J. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. Cell Host Microbe. 2017;21:603–610.e3. PubMed PMC
Shah R., Cope J.L., Nagy-Szakal D., Dowd S., Versalovic J., Hollister E.B., Kellermayer R. Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis. Gut Microb. 2016;7:384–396. PubMed PMC
Davis E.C., Dinsmoor A.M., Wang M., Donovan S.M. Microbiome Composition in Pediatric Populations from Birth to Adolescence: Impact of Diet and Prebiotic and Probiotic Interventions. Dig. Dis. Sci. 2020;65:706–722. PubMed PMC
Nusbaum D.J., Sun F., Ren J., Zhu Z., Ramsy N., Pervolarakis N., Kunde S., England W., Gao B., Fiehn O., et al. Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients. FEMS Microbiol. Ecol. 2018;94 PubMed PMC
Sartor R.B., Wu G.D. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology. 2017;152:327–339.e4. PubMed PMC
Mayorga L., Serrano-Gómez G., Xie Z., Borruel N., Manichanh C. Intercontinental Gut Microbiome Variances in IBD. Int. J. Mol. Sci. 2022;23 https://www.mdpi.com/1422-0067/23/18/10868 PubMed PMC
Pesoa S.A., Portela N., Fernández E., Elbarcha O., Gotteland M., Magne F. Comparison of Argentinean microbiota with other geographical populations reveals different taxonomic and functional signatures associated with obesity. Sci. Rep. 2021;11:7762. PubMed PMC
Zhou Y., Xu Z.Z., He Y., Yang Y., Liu L., Lin Q., Nie Y., Li M., Zhi F., Liu S., et al. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. mSystems. 2018;3 PubMed PMC
Douglas G.M., Hansen R., Jones C.M.A., Dunn K.A., Comeau A.M., Bielawski J.P., Tayler R., El-Omar E.M., Russell R.K., Hold G.L., et al. Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease. Microbiome. 2018;6:13. PubMed PMC
Wang X., Xiao Y., Xu X., Guo L., Yu Y., Li N., Xu C. Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease. Front. Cell. Infect. Microbiol. 2021;11 PubMed PMC
Zuo W., Wang B., Bai X., Luan Y., Fan Y., Michail S., Sun F. 16S rRNA and metagenomic shotgun sequencing data revealed consistent patterns of gut microbiome signature in pediatric ulcerative colitis. Sci. Rep. 2022;12:6421. PubMed PMC
Alipour M., Zaidi D., Valcheva R., Jovel J., Martínez I., Sergi C., Walter J., Mason A.L., Wong G.K.-S., Dieleman L.A., et al. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis. J. Crohns Colitis. 2016;10:462–471. PubMed PMC
Schirmer M., Denson L., Vlamakis H., Franzosa E.A., Thomas S., Gotman N.M., Rufo P., Baker S.S., Sauer C., Markowitz J., et al. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. Cell Host Microbe. 2018;24:600–610.e4. PubMed PMC
Lin H., Peddada S.D. Analysis of compositions of microbiomes with bias correction. Nat. Commun. 2020;11:3514. PubMed PMC
Cortez R.V., Moreira L.N., Padilha M., Bibas M.D., Toma R.K., Porta G., Taddei C.R. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis. Front. Immunol. 2020;11 PubMed PMC
Gevers D., Kugathasan S., Denson L.A., Vázquez-Baeza Y., Van Treuren W., Ren B., Schwager E., Knights D., Song S.J., Yassour M., et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15:382–392. PubMed PMC
Zeng M.Y., Inohara N., Nuñez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10:18–26. PubMed PMC
Lundberg S.M., Lee S.-I. In: Advances in Neural Information Processing Systems 30. Guyon I., Luxburg U.V., Bengio S., Wallach H., Fergus R., Vishwanathan S., Garnett R., editors. Curran Associates, Inc.; 2017. A Unified Approach to Interpreting Model Predictions [Internet] pp. 4765–4774.http://papers.nips.cc/paper/7062-a-unified-approach-to-interpreting-model-predictions.pdf
Hurych J., Mascellani Bergo A., Lerchova T., Hlinakova L., Kubat M., Malcova H., Cebecauerova D., Schwarz J., Karaskova E., Hecht T., et al. Faecal Bacteriome and Metabolome Profiles Associated with Decreased Mucosal Inflammatory Activity Upon Anti-TNF Therapy in Paediatric Crohn’s Disease. J. Crohns Colitis. 2024;18:106–120. PubMed PMC
Gasparetto M., Guariso G., Pozza L.V.D., Ross A., Heuschkel R., Zilbauer M. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy. BMC Gastroenterol. 2016;16:35. PubMed PMC
Mazor Y., Maza I., Kaufman E., Ben-Horin S., Karban A., Chowers Y., Eliakim R. Prediction of disease complication occurrence in Crohn’s disease using phenotype and genotype parameters at diagnosis. J. Crohns Colitis. 2011;5:592–597. PubMed
Gong D., Gong X., Wang L., Yu X., Dong Q. Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol. Res. Pract. 2016;2016 PubMed PMC
Abbas-Egbariya H., Haberman Y., Braun T., Hadar R., Denson L., Gal-Mor O., Amir A. Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Genome Biol. 2022;23:61. PubMed PMC
Lu H., Xu X., Fu D., Gu Y., Fan R., Yi H., He X., Wang C., Ouyang B., Zhao P., et al. Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis. Cell Host Microbe. 2022;30:1139–1150.e7. PubMed
Liu D., Xie L.-S., Lian S., Li K., Yang Y., Wang W.-Z., Hu S., Liu S.-J., Liu C., He Z. Anaerostipes hadrus, a butyrate-producing bacterium capable of metabolizing 5-fluorouracil. mSphere. 2024;9 PubMed PMC
Islam S.M.S., Ryu H.-M., Sayeed H.M., Byun H.-O., Jung J.-Y., Kim H.-A., Suh C.-H., Sohn S. Eubacterium rectale attenuates HSV-1 induced systemic inflammation in mice by inhibiting CD83. Front. Immunol. 2021;12 PubMed PMC
Kim G.-H., Lee K., Shim J.O. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets. Microbiol. Spectr. 2023;11 PubMed PMC
Herlemann D.P., Labrenz M., Jürgens K., Bertilsson S., Waniek J.J., Andersson A.F. Transitions in bacterial communities along the 2000 km salinity gradient of the Baltic Sea. ISME J. 2011;5:1571–1579. PubMed PMC
Sun S., Wang H., Tsilimigras M.C., Howard A.G., Sha W., Zhang J., Su C., Wang Z., Du S., Sioda M., et al. Does geographical variation confound the relationship between host factors and the human gut microbiota: a population-based study in China. BMJ Open. 2020;10 PubMed PMC
Del Chierico F., Abbatini F., Russo A., Quagliariello A., Reddel S., Capoccia D., Caccamo R., Ginanni Corradini S., Nobili V., De Peppo F., et al. Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns. Front. Microbiol. 2018;9:1210. PubMed PMC
Clooney A.G., Fouhy F., Sleator R.D., O’ Driscoll A., Stanton C., Cotter P.D., Claesson M.J. Comparing Apples and Oranges?: Next Generation Sequencing and Its Impact on Microbiome Analysis. PLoS One. 2016;11 PubMed PMC
Liñares-Blanco J., Fernandez-Lozano C., Seoane J.A., López-Campos G. Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes. Front. Microbiol. 2022;13 PubMed PMC
Dadkhah E., Sikaroodi M., Korman L., Hardi R., Baybick J., Hanzel D., Kuehn G., Kuehn T., Gillevet P.M. Gut microbiome identifies risk for colorectal polyps. BMJ Open Gastroenterol. 2019;6 PubMed PMC
Moon J.S. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr. Gastroenterol. Hepatol. Nutr. 2019;22:50–56. PubMed PMC
Seegers J.F.M.L., Gül I.S., Hofkens S., Brosel S., Schreib G., Brenke J., Donath C., de Vos W.M. Toxicological safety evaluation of live Anaerobutyricum soehngenii strain CH106. J. Appl. Toxicol. 2022;42:244–257. PubMed PMC
Kostic A.D., Xavier R.J., Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489–1499. PubMed PMC
Fitzgerald R.S., Sanderson I.R., Claesson M.J. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome. Microb. Ecol. 2021;82:833–844. PubMed PMC
Teitelbaum J.E., Triantafyllopoulou M. Inflammatory bowel disease and Streptococcus bovis. Dig. Dis. Sci. 2006;51:1439–1442. PubMed
Zhang Q., Su X., Zhang C., Chen W., Wang Y., Yang X., Liu D., Zhang Y., Yang R. Klebsiella pneumoniae Induces Inflammatory Bowel Disease Through Caspase-11-Mediated IL18 in the Gut Epithelial Cells. Cell. Mol. Gastroenterol. Hepatol. 2023;15:613–632. PubMed PMC
Ijaz U.Z., Quince C., Hanske L., Loman N., Calus S.T., Bertz M., Edwards C.A., Gaya D.R., Hansen R., McGrogan P., et al. The distinct features of microbial “dysbiosis” of Crohn’s disease do not occur to the same extent in their unaffected, genetically-linked kindred. PLoS One. 2017;12 PubMed PMC
Turner D., Bishai J., Reshef L., Abitbol G., Focht G., Marcus D., Ledder O., Lev-Tzion R., Orlanski-Meyer E., Yerushalmi B., et al. Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. Inflamm. Bowel Dis. 2020;26:1733–1742. PubMed
Chen S., Zhou Y., Chen Y., Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884–i890. PubMed PMC
Edgar R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–2461. PubMed
Rognes T., Flouri T., Nichols B., Quince C., Mahé F. VSEARCH: a versatile open source tool for metagenomics. PeerJ. 2016;4 PubMed PMC
Steinegger M., Söding J. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat. Biotechnol. 2017;35:1026–1028. PubMed
McMurdie P.J., Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8 PubMed PMC
Ma S., Shungin D., Mallick H., Schirmer M., Nguyen L.H., Kolde R., Franzosa E., Vlamakis H., Xavier R., Huttenhower C. Population structure discovery in meta-analyzed microbial communities and inflammatory bowel disease using MMUPHin. Genome Biol. 2022;23:208. PubMed PMC
Oksanen J., Blanchet F.G., Friendly M., Kindt R., Legendre P., McGlinn D., Minchin P.R., O’hara R., Simpson G., Solymos P., et al. The Comprehensive R Archive Network; 2019. Vegan: Community Ecology Package.
Fernandes A.D., Reid J.N., Macklaim J.M., McMurrough T.A., Edgell D.R., Gloor G.B. Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome. 2014;2:15. PubMed PMC